Clinical phase III trials of the Bharat Biotech's COVID-19 nasal vaccine completed
June 26, 2026
  • Read Ecopy
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Android AppiPhone AppArattai
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
Organiser
  • Home
  • Bharat
  • World
  • Operation Sindoor
  • Editorial
  • Analysis
  • Opinion
  • Culture
  • Defence
  • International Edition
  • RSS @ 100
  • Magazine
  • Read Ecopy
Home Bharat

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France.

WEBDESKWEBDESK
Jun 19, 2022, 12:20 pm IST
in Bharat
Follow on Google News
FacebookTwitterWhatsAppTelegramEmail

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data to the Drugs Controller General of India (DCGI) next month.

In an exclusive interview with ANI, Dr Ella said, “We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world’s first clinically proven nasal COVID-19 vaccine”.

Krishna was in Paris as a speaker at Viva Technology 2022 where India was declared country of the year. India’s drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its COVID-19 nasal vaccine. On the booster dose of COVID-19, Krishna said that those who had taken the second dose must take the booster dose.

“Booster dose of vaccine gives immunity. I always say the booster dose is a miracle dose for every vaccination. Even in children first, two doses don’t give much immunity, but the third dose gives an amazing response to the child. The same thing for adults also. The third dose is very important for adults. COVID-19 can’t be eradicated 100 per cent. It will be there and we have to live with it and handle it and more intelligently how to control it,” he said.

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France. “I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997.”

He said that earlier United States was the centre of startups but for the first time Indians are getting exposure in France. “I am so happy to say the French government is very practical. They are really encouraging India and with truthfully a good heart. Again, they are really pushing how more the government can work together. How about the country’s startups can work together?”, he said.

“How government policies can create an ecosystem that is scalable, even French President Macron was talking about how to scale it up between the two partnerships, how to scale up for globe and the digitalization all that is talking about infrastructure, digitalization all that they are talking and that is a good sign between the two countries and the first time French is coming closer to India,” he added.

 

Topics: IndiaCOVID-19Bharat BiotechCOVID vaccine
ShareTweetSendShareSend
✮ Subscribe Organiser YouTube Channel. ✮
✮ Join Organiser's WhatsApp channel for Nationalist views beyond the news. ✮
Previous News

PM Modi inaugurates Pragati Maidan Integrated Transit Corridor project in Delhi

Next News

Lok Sabha speaker Om Birla completes 3 years in office; Lok Sabha saves Rs 668.86 crore

Related News

The Emergency: India’s darkest chapter, the struggle for democracy and the ban on the RSS

Exposing Western Media’s Climate Hypocrisy: When Europe burns it’s just weather, When India heats up it’s a crisis

UAE President Sheikh Mohamed bin Zayed Al Nahyan and Prime Minister Narendra Modi(File Photo)

UAE to buy BrahMos & Akashteer: Big win for India’s defence ecosystem to seal regional security amid West Asia crisis

United States Trade Representative Jamieson Greer and Union Commerce and Industry Minister Piyush Goyal

India-US Trade Agreement: Historic deal enters final stretch as USTR Jamieson Greer heads to New Delhi

Universities Adopt ‘Bharat’ on Degrees and Certificates

Madhya Pradesh: ‘Bharat’ replaces ‘India’ on degrees as academic institutions reclaim ancient identity

Representative Image

Europe’s Supremacy: A manufactured narrative imposed via colonial power is counterd by India’s civilizational memory

Load More

Latest News

Y.D. Manjunath, Additional Excise Commissioner and brother-in-law of Karnataka PWD Minister Satish Jarkiholi

ED raids Karnataka Excise Dept officials: Rs 13.3 Cr seized, Minister Satish Jarkiholi’s brother-in-law under scanner

Former -DMK Minister EV Velu (File Photo)

Tamil Nadu: Anti-graft agency raids 13 locations linked to ex-DMK Minister EV Velu over alleged contract irregularities

Government introduces AIR SUVIDHA portal following WHO Ebola emergency for international travellers

The Emergency: India’s darkest chapter, the struggle for democracy and the ban on the RSS

Exposing Western Media’s Climate Hypocrisy: When Europe burns it’s just weather, When India heats up it’s a crisis

Rahul Gandhi’s 2018 Panama Papers Remark: Congress leader apologetic in MP High Court, but political fallout continues

UP Govt orders audit of various coaching centres that are illegally constructed

Lucknow Coaching Fire: UP CM Yogi Adityanath orders statewide fire safety audit, forms special teams across districts

India’s education debate needs clarity, not noise

Scuffle at the Tiruvananthapuram Municipal Corporation on June 25

Keralam: Nine BJP councillors injured as CPM protest demanding Mayor’s resignation turns violent at Thiruvananthapuram

India's textile ambitions are being woven through local manufacturing strengths, innovation, sustainability and an expanding global trade footprint

National Textile Export Roadmap 2030: India’s strategic push for a $100 billion global textile presence

Load More
  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

  • Home
  • Search Organiser
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
  • Editorial
  • Operation Sindoor
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS @ 100
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
  • Subscribe Magazine
  • Read Ecopy
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies